Literature DB >> 24551419

Validation and enhancement of a computable medication indication resource (MEDI) using a large practice-based dataset.

Wei-Qi Wei1, Jonathan D Mosley2, Lisa Bastarache1, Joshua C Denny3.   

Abstract

Linking medications with their indications is important for clinical care and research. We have recently developed a freely-available, computable medication-indication resource, called MEDI, which links RxNorm medications to indications mapped to ICD9 codes. In this paper, we identified the medications and diagnoses for 1.3 million individuals at Vanderbilt University Medical Center to evaluate the medication coverage of MEDI and then to calculate the prevalence for each indication for each medication. Our results demonstrated MEDI covered 97.3% of medications recorded in medical records. The "high precision subset" of MEDI covered 93.8% of recorded medications. No significant prescription drugs were missed by MEDI. Manual physician review of random patient records for four example medications found that the MEDI covered the observed indications, and confirmed the estimated prevalence of these medications using practice information. Indication prevalence information for each medication, previously unavailable in other public resources, may improve the clinical usability of MEDI. We believe MEDI will be useful for both clinical informatics and to aid in recognition of phenotypes for electronic medical record-based research.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24551419      PMCID: PMC3900157     

Source DB:  PubMed          Journal:  AMIA Annu Symp Proc        ISSN: 1559-4076


  26 in total

1.  The challenge of measuring quality of care from the electronic health record.

Authors:  Carol P Roth; Yee-Wei Lim; Joshua M Pevnick; Steven M Asch; Elizabeth A McGlynn
Journal:  Am J Med Qual       Date:  2009-05-29       Impact factor: 1.852

Review 2.  'Deep phenotyping': characterizing populations in the era of genomics and systems biology.

Authors:  Russell P Tracy
Journal:  Curr Opin Lipidol       Date:  2008-04       Impact factor: 4.776

3.  Portability of an algorithm to identify rheumatoid arthritis in electronic health records.

Authors:  Robert J Carroll; Will K Thompson; Anne E Eyler; Arthur M Mandelin; Tianxi Cai; Raquel M Zink; Jennifer A Pacheco; Chad S Boomershine; Thomas A Lasko; Hua Xu; Elizabeth W Karlson; Raul G Perez; Vivian S Gainer; Shawn N Murphy; Eric M Ruderman; Richard M Pope; Robert M Plenge; Abel Ngo Kho; Katherine P Liao; Joshua C Denny
Journal:  J Am Med Inform Assoc       Date:  2012-02-28       Impact factor: 4.497

4.  Variants near FOXE1 are associated with hypothyroidism and other thyroid conditions: using electronic medical records for genome- and phenome-wide studies.

Authors:  Joshua C Denny; Dana C Crawford; Marylyn D Ritchie; Suzette J Bielinski; Melissa A Basford; Yuki Bradford; High Seng Chai; Lisa Bastarache; Rebecca Zuvich; Peggy Peissig; David Carrell; Andrea H Ramirez; Jyotishman Pathak; Russell A Wilke; Luke Rasmussen; Xiaoming Wang; Jennifer A Pacheco; Abel N Kho; M Geoffrey Hayes; Noah Weston; Martha Matsumoto; Peter A Kopp; Katherine M Newton; Gail P Jarvik; Rongling Li; Teri A Manolio; Iftikhar J Kullo; Christopher G Chute; Rex L Chisholm; Eric B Larson; Catherine A McCarty; Daniel R Masys; Dan M Roden; Mariza de Andrade
Journal:  Am J Hum Genet       Date:  2011-10-07       Impact factor: 11.025

5.  Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping.

Authors:  J S Schildcrout; J C Denny; E Bowton; W Gregg; J M Pulley; M A Basford; J D Cowan; H Xu; A H Ramirez; D C Crawford; M D Ritchie; J F Peterson; D R Masys; R A Wilke; D M Roden
Journal:  Clin Pharmacol Ther       Date:  2012-06-27       Impact factor: 6.875

Review 6.  Deep phenotyping for precision medicine.

Authors:  Peter N Robinson
Journal:  Hum Mutat       Date:  2012-05       Impact factor: 4.878

7.  The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies.

Authors:  Catherine A McCarty; Rex L Chisholm; Christopher G Chute; Iftikhar J Kullo; Gail P Jarvik; Eric B Larson; Rongling Li; Daniel R Masys; Marylyn D Ritchie; Dan M Roden; Jeffery P Struewing; Wendy A Wolf
Journal:  BMC Med Genomics       Date:  2011-01-26       Impact factor: 3.063

Review 8.  Measuring the quality of medication use in older adults.

Authors:  Mary T Roth; Morris Weinberger; William H Campbell
Journal:  J Am Geriatr Soc       Date:  2009-04-16       Impact factor: 5.562

9.  Large-scale prediction of adverse drug reactions using chemical, biological, and phenotypic properties of drugs.

Authors:  Mei Liu; Yonghui Wu; Yukun Chen; Jingchun Sun; Zhongming Zhao; Xue-wen Chen; Michael Edwin Matheny; Hua Xu
Journal:  J Am Med Inform Assoc       Date:  2012-06       Impact factor: 4.497

10.  Improving drug abuse treatment delivery through adoption of harmonized electronic health record systems.

Authors:  Udi E Ghitza; Steven Sparenborg; Betty Tai
Journal:  Subst Abuse Rehabil       Date:  2011-07-01
View more
  11 in total

Review 1.  Medication-indication knowledge bases: a systematic review and critical appraisal.

Authors:  Hojjat Salmasian; Tran H Tran; Herbert S Chase; Carol Friedman
Journal:  J Am Med Inform Assoc       Date:  2015-09-02       Impact factor: 4.497

2.  Combining billing codes, clinical notes, and medications from electronic health records provides superior phenotyping performance.

Authors:  Wei-Qi Wei; Pedro L Teixeira; Huan Mo; Robert M Cronin; Jeremy L Warner; Joshua C Denny
Journal:  J Am Med Inform Assoc       Date:  2015-09-02       Impact factor: 4.497

3.  Assessing the role of a medication-indication resource in the treatment relation extraction from clinical text.

Authors:  Cosmin Adrian Bejan; Wei-Qi Wei; Joshua C Denny
Journal:  J Am Med Inform Assoc       Date:  2014-10-21       Impact factor: 4.497

4.  A Data-Driven Reference Standard for Adverse Drug Reaction (RS-ADR) Signal Assessment: Development and Validation.

Authors:  Suehyun Lee; Jeong Hoon Lee; Grace Juyun Kim; Jong-Yeup Kim; Hyunah Shin; Inseok Ko; Seon Choe; Ju Han Kim
Journal:  J Med Internet Res       Date:  2022-10-06       Impact factor: 7.076

5.  Extracting research-quality phenotypes from electronic health records to support precision medicine.

Authors:  Wei-Qi Wei; Joshua C Denny
Journal:  Genome Med       Date:  2015-04-30       Impact factor: 11.117

6.  Monitoring prescribing patterns using regression and electronic health records.

Authors:  Daniel Backenroth; Herbert S Chase; Ying Wei; Carol Friedman
Journal:  BMC Med Inform Decis Mak       Date:  2017-12-19       Impact factor: 2.796

Review 7.  Overcoming cancer therapeutic bottleneck by drug repurposing.

Authors:  Zhe Zhang; Li Zhou; Na Xie; Edouard C Nice; Tao Zhang; Yongping Cui; Canhua Huang
Journal:  Signal Transduct Target Ther       Date:  2020-07-02

8.  Lyme Disease Patient Trajectories Learned from Electronic Medical Data for Stratification of Disease Risk and Therapeutic Response.

Authors:  Osamu Ichikawa; Benjamin S Glicksberg; Nicholas Genes; Brian A Kidd; Li Li; Joel T Dudley
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

9.  INSIdE NANO: a systems biology framework to contextualize the mechanism-of-action of engineered nanomaterials.

Authors:  Angela Serra; Ivica Letunic; Vittorio Fortino; Richard D Handy; Bengt Fadeel; Roberto Tagliaferri; Dario Greco
Journal:  Sci Rep       Date:  2019-01-17       Impact factor: 4.379

10.  A Literature-Based Knowledge Graph Embedding Method for Identifying Drug Repurposing Opportunities in Rare Diseases.

Authors:  Daniel N Sosa; Alexander Derry; Margaret Guo; Eric Wei; Connor Brinton; Russ B Altman
Journal:  Pac Symp Biocomput       Date:  2020
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.